Eureka Therapeutics
PrivateLast Round
Grant
Jun 6, 2023
Total Funding Raised
$136.6M
Company Overview
Eureka Therapeutics is a biotechnology company specializing in antibody-drug discovery technology that provides innovative therapeutic antibody treatments and novel cell therapies for solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eureka Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Eureka Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 6, 2023 | ||||
| Series E | Mar 17, 2020 | ||||
| Series D | Jan 22, 2018 | ||||
| Series C | Sep 24, 2014 |
Key People
Founding team and executive leadership
Eureka Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Acorn Campus Ventures | Series D, Series C |
| Suma Venture | Series C, Series D |
| California Institute for Regenerative Medicine | Grant |
| Yuan Capital | Series D, Series C |
| Harbinger Venture Capital | Series C, Series D |
| 金浦产业投资基金管理有限公司 | Series D |
| Acorn Pacific Ventures | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 22, 2025
Added Iwai Chem, a chemicals/distribution SMB, as a customer.
- Aug 12, 2025
William S. Solari III has joined the Board of Directors.
Eureka Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Eureka Therapeutics's valuation, stock price, and market status.
